US$ 24.61
glp 1 and kidneys Glucagon-like Peptide-1 Receptor Agonists Diabetic Kidney Disease: From Bench to Bed-Side GLP−1 Receptor Agonist Mechanisms GLP−1RAs
Description
GLP-1s are shaking up the playbook and giving pharma companies a whole new set of moves to master
Tirzepatide (Zepbound/Mounjaro): A dual GLP-1/GIP receptor agonist undergoing evaluation for MASH after demonstrating significant liver fat reduction in studies.Retatrutide: A "triple agonist" targeting GLP-1, GIP, and glucagon (GCGR) receptors, which has shown "unprecedented" efficacy in weight loss and is being evaluated for metabolic diseases including MASH

Considering coming off Ozempic cold turkey

this week
At Genesis Lifestyle Medicine in Denver, we incorporate GLP-1s into our personalized medical weight loss programs to help you achieve your health goals

GLP-1 medications offer metabolic benefits for many patients, but specific contraindications and risk factors determine who should not use them